A photo of Lori Luchtman-Jones.

Medical Director, Hemostasis & Thrombosis Laboratory

Director, Thrombosis Research

Medical Director, Division of Hematology

Professor, UC Department of Pediatrics



Board Certified

Best Doctors logo

"I believe that people want to be healthy and strong, and by working together we can find a way forward. When patients, families and medical staff work together, the impossible can become possible."

My Biography & Research


I’m a board-certified pediatric hematologist-oncologist, or blood doctor. Early in my career I worked as an oncologist and bone marrow transplant doctor. I now specialize in pediatric hematology with a focus on hemostasis and thrombosis (blood clotting disorders). I am also a member of the Cerebrovascular Program at Cincinnati Children’s, where I work to improve the diagnosis and management of pediatric stroke.

I chose my career because I love children — especially adolescents and young adults. I am inspired by the honesty and courage of my patients. Having to take medicine every day or having limitations on activity or endurance is difficult. However, I believe that people want to be healthy and strong, and by working together we can find a way forward. When patients, families and medical staff work together, the impossible can become possible.

I am always looking for ways to improve outcomes. In addition to my clinical practice, I conduct research and direct a clinical laboratory where we look for solutions to bleeding and clotting problems. My team and I are trying to understand the connections between diseases like inflammatory disorders or sickle cell anemia and clotting. We also look for better ways to diagnose problems with platelet function.

Outside of the hospital, I enjoy cooking, growing herbs and reading mystery books. I also like to rehab old houses.

Additional Languages


Clinical Interests

Pediatric hematology: thrombosis; hemostasis; stroke

Research Interests

Thrombosis; stroke

Academic Affiliation

Professor, UC Department of Pediatrics

Clinical Divisions

Cancer and Blood Diseases, Cerebrovascular, Cardio-Oncology, Hemophilia, Thrombosis

Research Divisions

Cancer and Blood Diseases, Hematology

My Locations

My Education

MD: University of California, San Diego, San Diego, CA, 1987.

Residency: Pediatrics, University of California San Diego School of Medicine, San Diego, CA, 1990.

Fellowship: Pediatric Hematology Oncology, Washington University in St. Louis School of Medicine/St. Louis Children’s Hospital, St. Louis, MO, 1994.

Certification: Pediatrics 1990; Pediatric Hematology Oncology, 1996 - present.

My Publications

Impact of exogenous antithrombin on low molecular weight heparin anti-Xa activity assays in a pediatric and young adult leukemia and lymphoma cohort with variable antithrombin levels. Schaefer, B; Hausfeld, A; Martin, M; Steele, P; Martin, J; Reher, SR; Lane, A; Luchtman-Jones, L. Pediatric Blood and Cancer. 2020; 67.

Extreme Thrombocytosis after Pediatric Pancreatectomy with Islet Autotransplantation Is Unique Compared to Other Postsplenectomy States. Boucher, AA; Luchtman-Jones, L; Palumbo, JS; Cancelas, JA; Abu-El-Haija, M; Jenkins, TM; Lin, TK; Nathan, JD. Journal of Pediatric Surgery. 2020; 55:1645-1650.

Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia. Zhang, X; Kershaw, KN; Minniti, CP; Campbell, A; Rana, SR; Darbari, DS; Luchtman-Jones, L; Sable, C; Dham, N; Ensing, G; et al. Blood Advances. 2020; 4:3311-3314.

Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study. Nouraie, M; Darbari, DS; Rana, S; Minniti, CP; Castro, OL; Luchtman-Jones, L; Sable, C; Dham, N; Kato, GJ; Gladwin, MT; et al. American Journal of Hematology. 2020; 95:766-774.

Aspirin in childhood acute ischemic stroke: The evidence for treatment and efficacy testing. Boucher, AA; Taylor, JM; Luchtnnan-Jones, L. Pediatric Blood and Cancer. 2019; 66:e27665-e27665.

Capped antithrombin III dosing is cost effective in the management of asparaginase-associated thrombosis. Young, J; Sawyer, J; Jenkins, M; O'Brien, M; Luchtman-Jones, L; Breese, EH. Pediatric Blood and Cancer. 2019; 66:e27719-e27719.

Thrombopoietin Contributes to Extreme Thrombocytosis After Pediatric Pancreatectomy With Islet Autotransplantation. Gurria, JP; Boucher, AA; Hornung, L; Palumbo, JS; Badia, P; Luchtman-Jones, L; Abu-El-Haija, M; Lin, TK; Nathan, JD. Pancreas. 2019; 48:652-655.

Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient. Jones, L; Dandoy, C; Jodele, S; Myers, KC; Luchtman-Jones, L; Quinn, CT; Mullins, E; El-Bietar, J. Bone Marrow Transplantation. 2018; 53:487-489.

Successful liver transplantation for homozygous protein C deficiency with a type II mutation using a heterozygous living related donor. Boucher, AA; Luchtman-Jones, L; Nathan, JD; Palumbo, JS. American Journal of Hematology. 2018; 93:462-466.

Knowledge insufficient: the management of haemoglobin SC disease. Pecker, LH; Schaefer, BA; Luchtman-Jones, L. British Journal of Haematology. 2017; 176:515-526.